Clarius Group LLC’s GSK GSK Stock Holding History

Clarius Group LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$264K	Hold	5,378	–	–	0.02%	315
2025 Q3	$232K	Sell	5,378 -714	-12%	-$27.9K	0.01%	352
2025 Q2	$234K	Hold	6,092	–	–	0.01%	420
2025 Q1	$236K	Buy	+6,092	New	+$223K	0.01%	419
2024 Q3	–	Sell	-5,514	Closed	-$212K	–	463
2024 Q2	$212K	Sell	5,514 -1,997	-27%	-$84K	0.02%	405
2024 Q1	$322K	Sell	7,511 -429	-5%	-$17.7K	0.02%	316
2023 Q4	$294K	Buy	7,940 +68	+0.9%	+$2.44K	0.02%	357
2023 Q3	$285K	Sell	7,872 -561	-7%	-$19.9K	0.03%	347
2023 Q2	$301K	Buy	8,433 +732	+10%	+$26.3K	0.02%	390
2023 Q1	$274K	Sell	7,701 -2,831	-27%	-$99K	0.02%	408
2022 Q4	$370K	Buy	+10,532	New	+$351K	0.03%	320
2022 Q3	–	Sell	-5,015	Closed	-$273K	–	506
2022 Q2	$273K	Buy	5,015 +268	+6%	+$14.8K	0.03%	361
2022 Q1	$262K	Hold	4,747	–	–	0.02%	400
2021 Q4	$262K	Buy	+4,747	New	+$247K	0.02%	400
2020 Q3	–	Sell	-4,026	Closed	-$205K	–	309
2020 Q2	$205K	Sell	4,026 -587	-13%	-$30.1K	0.03%	266
2020 Q1	$218K	Sell	4,613 -510	-10%	-$27.2K	0.04%	228
2019 Q4	$305K	Sell	5,123 -7	-0.1%	-$389	0.05%	199
2019 Q3	$274K	Buy	5,130 +658	+15%	+$33.9K	0.05%	207
2019 Q2	$224K	Buy	+4,472	New	+$224K	0.05%	224

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Clarius Group LLC's GSK Position: Q4 2025 in Review

Clarius Group LLC held its GSK (GSK) position steady in Q4 2025 at 5,378 shares worth $264K. The position accounts for 0.02% of the portfolio, ranked #315.

Clarius Group LLC first reported a position in GSK in Q2 2019 and has held it in 19 quarters since. The position peaked at $370K in Q4 2022. 996 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

Clarius Group LLC held 5,378 shares of GSK worth $264K as of Q4 2025.
Clarius Group LLC left its GSK share count unchanged in Q4 2025.
GSK made up 0.02% of Clarius Group LLC's portfolio in Q4 2025, its #315 holding.
Clarius Group LLC first reported a position in GSK in Q2 2019 and has held it in 19 quarters since.
Clarius Group LLC's GSK position peaked at $370K in Q4 2022.
996 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.